(19)
(11) EP 4 164 645 A1

(12)

(43) Date of publication:
19.04.2023 Bulletin 2023/16

(21) Application number: 21825172.6

(22) Date of filing: 14.06.2021
(51) International Patent Classification (IPC): 
A61K 31/47(2006.01)
A61K 31/5365(2006.01)
 A61K 31/4965(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4965; A61K 31/5365; A61K 31/4709; A61K 9/2077; A61K 9/10; A61K 9/1652
 
C-Sets:
  1. A61K 31/5365, A61K 2300/00;
  2. A61K 31/4709, A61K 2300/00;
  3. A61K 31/4965, A61K 2300/00;
(86) International application number:
PCT/US2021/037252
(87) International publication number:
WO 2021/257466 (23.12.2021 Gazette 2021/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.06.2020 IN 202041025104

(71) Applicant: The Global Alliance for TB Drug Development, Inc.
New York, NY 10005 (US)

(72) Inventors:
  • TANEJA, Rajneesh
    New York, NY 10025 (US)
  • SINGH, Pirthi, Pal
    Hyderabad 500049 (IN)
  • VITHALAPURAM, Veena
    Hyderabad 500049 (IN)
  • NADIGOTI, Jagadeesh
    Hyderabad 500049 (IN)

(74) Representative: dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB 
Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln
50667 Köln (DE)

   


(54) COMBINATION ANTIBACTERIAL COMPOSITION AND METHOD FOR ANTIBACTERIAL THERAPY